Popularity #2,179Earnings today
RZLT · NASDAQ · Biotechnology

Rezolute (RZLT)

Developing ersodetug for hypoglycemia caused by congenital and tumor hyperinsulinism.

$4.03
vs last close−0.01 (−0.37%)